Biodistribution and Antitumor Effect of Adriamycin Encapsulated in Long-Circulating Liposomes Containing Amphipathic Polyethylene Glycol or Ganglioside G_M1

References

• Gregoriadis G. The liposome drug-carrier concept: its development and future. “Liposomes in Biological Systems.”, G. Gregoriadis, A.C. Allison. John Wiley and Sons Ltd., New York 1980; 25
   Google Scholar
• Weinstein J.N. Liposomes as drug carriers in cancer therapy. Cancer Treat. Rep. 1984; 68: 127
   PubMedGoogle Scholar
• Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 1982; 42: 1412
   PubMed Web of Science ®Google Scholar
• Hwang K.J. Liposome Pharmacokinetics. “Liposome from biophysics to therapeutics.”, M.J. Ostro. Maecel Dekker Inc., New York 1987; 109
   Google Scholar
• Senior J.H. Fate and behavior in vivo: a review of controlling factors. Critical Review in Drug Carrier Systems. 1987; 3: 123
   PubMed Web of Science ®Google Scholar
• Allen T.M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987; 223: 42
   PubMed Web of Science ®Google Scholar
• Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial system and other tissues. Biochim. Biophys. Acta 1989; 981: 27
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988; 85: 6949
   PubMed Web of Science ®Google Scholar
• Gabizon A., Price D.C., Huberty J., Bresalier R.S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res. 1990; 50: 6371
   PubMed Web of Science ®Google Scholar
• Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268: 235
   PubMed Web of Science ®Google Scholar
• Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991; 1062: 142
   Google Scholar
• Maruyama K., Yuda T., Okamoto A., Ishikura C., Kojima S., Iwatsuru M. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull. 1991; 39: 1620
   PubMed Web of Science ®Google Scholar
• Yuda T., Maruyama K., Okamoto A., Ishikura C., Iwatsuru M. Polyethyleneglycols effectively increase the liposome concentration in blood circulation. Drug Delivery System 1991; 6: 433
   Google Scholar
• Blume G., Cevec G. Liposomes for sustained drug release in vivo. Biochim. Biophys. Acta 1990; 1029: 91
   PubMed Web of Science ®Google Scholar
• Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly (ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1991; 1062: 77
   Google Scholar
• Allen T.M., Hansen C., Martin F., Redemann C., Young A.Y. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1991; 1066: 29
   Google Scholar
• Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1992; 1128: 44
   Google Scholar
• Allen T.M., Mehra T., Hansen C., Chin Y.C. Stealth liposomes: an improved sustained release system for 1-b-D-arabinofuranosylcytosine. Cancer Res. 1992; 52: 2431
   PubMed Web of Science ®Google Scholar
• Young R.C., Ozols R.F., Myers C.E. The anthracycline antineoplastic drugs. N.Engl. J. Med. 1981; 305: 139
   PubMed Web of Science ®Google Scholar
• Wang J.J., Cortes E., Sinks L.F., Holland J.F. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer 1971; 28: 837
   PubMed Web of Science ®Google Scholar
• Rahman A., Kessler A., More N., Sikic B., Rowden G., Woolley P., Schein P.S. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 1980; 40: 1532
   PubMed Web of Science ®Google Scholar
• Olson F., Mayhew E., Maslow D., Rustum Y., Szoka F. Characterization, toxicity, and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol. 1982; 18: 167
   PubMedGoogle Scholar
• Gabizon A., Meshorer A., Barenholz Y. J. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J. Natl. Cancer Inst. 1986; 77: 459
   Google Scholar
• Sommerman E.F., Pritchard P.H., Cullis P.R. 125I labeled inulin. A convenient marker for deposition of liposomal contents in vivo. Biochem. Biophys. Res. Commun. 1984; 122: 319
   PubMed Web of Science ®Google Scholar
• Kates M. Techniques of Lipidology. Elsevier, New York 1972
   Google Scholar
• Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978; 75: 4194
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Bally M.B., Hope M.J., Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to membrane potential. Biochim. Biophys. Acta 1985; 816: 294
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Bally M.B., Cullis P.R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta 1986; 857: 123
   PubMed Web of Science ®Google Scholar
• Bartlett G.R. Phosphorus assay in column chromatography. J Biol.Chem. 1959; 234: 466
   PubMed Web of Science ®Google Scholar
• Maruyama K., Unezaki S., Takahashi N., Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1993; 1149: 209
   PubMed Web of Science ®Google Scholar
• Wu M.S., Robbins J.C., Bugianesi R.L., Ponpipom M.M., Shen T.Y. Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim. Biophys. Acta 1981; 674: 19
   PubMed Web of Science ®Google Scholar
• Bachur N.R., Moore A.L., Bernstein J.G., Liu A. Tissue distribution and disposition of daunomycin in mice: fluorometric and isotopicmethods. Cancer Chemother. Rep. 1970; 54: 89
   PubMedGoogle Scholar
• Druckmann S., Gabizon A., Barenholz A. Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetics studies. Biochim. Biophys. Acta 1989; 980: 381
   Google Scholar
• Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 1981; 4: 879
   PubMedGoogle Scholar
• Bally M.B., Nayer R., Masin D., Hope M.J., Cullis P.R., Mayer L.D. Liposomes with entrapped doxorubicin exhibit extended blood residence time. Biochim. Biophys. Acta 1990; 1023: 133
   PubMed Web of Science ®Google Scholar
• Cowens J.W., Creaven P.J., Brenner D.E., Ginsberg R., Petrelli N., Huben R., Karakusis C., Douglass H., Mayer L., Bally M., Cullis P., Goolsby H., Solomon J. Phase I study of doxorubicin encapsulated in liposomes. Proc. Am. Soc. Clin. Oncol. 1990; 9: 87
   Google Scholar
• Gabizon A., Dagan A., Goren D., Barenholz Y., Fuks Z. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 1982; 42: 4734
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989; 49: 5922
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Stericallystabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 1991; 88: 11460
   PubMed Web of Science ®Google Scholar
• Gabizon A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 1992; 52: 891
   PubMed Web of Science ®Google Scholar